Dyshidrotic Eczema in Two Patients on Secukinumab for Plaque Psoriasis: A Case Report

SAGE Open Medical Case Reports
doi 10.1177/2050313x20904561
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Secukinumab: First IL-17A Antagonist for Plaque Psoriasis

Pharmacy Today
2015English

Drug Survival of Secukinumab in Real-World Plaque Psoriasis Patients: A 52-Week, Multicenter, Retrospective Study

Journal of the American Academy of Dermatology
Dermatology
2018English

Efficacy of Secukinumab in Patients With Plaque Psoriasis: Area Under the Curve of Treatment Response Rates

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Image Gallery: Resolution of Lichen Striatus in a Patient With Coexisting Chronic Plaque Psoriasis and Vitiligo During Secukinumab Treatment

British Journal of Dermatology
DermatologyMedicine
2017English

A Novel Molecular Disease Classifier for Psoriasis and Eczema

Experimental Dermatology
BiochemistryDermatologyMolecular Biology
2016English

Therapy Response Was Not Altered by HLA-Cw6 Status in Psoriasis Patients Treated With Secukinumab: A Retrospective Case Series

Journal of the European Academy of Dermatology and Venereology
DermatologyInfectious Diseases
2018English

Risankizumab vs. Ustekinumab for Plaque Psoriasis

British Journal of Dermatology
DermatologyMedicine
2019English

Long-Term Clinical Efficacy and Safety of Secukinumab for Japanese Patients With Psoriasis: A Single-Center Experience

Journal of Dermatology
DermatologyMedicine
2017English

Long-Term Safety of Adalimumab in Adult Patients With Plaque Psoriasis

British Journal of Dermatology
DermatologyMedicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy